A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Hoosier Cancer Research Network
Hoosier Cancer Research Network
National Cancer Institute (NCI)
AHS Cancer Control Alberta
Jonsson Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Stanford University
University of Utah
Swiss Cancer Institute
New Mexico Cancer Research Alliance